Literature DB >> 10524969

Bordetella pertussis and chronic cough in adults.

N H Birkebaek1, M Kristiansen, T Seefeldt, J Degn, A Moller, I Heron, P L Andersen, J K Moller, L Ostergård.   

Abstract

To evaluate Bordetella pertussis as a cause of persistent cough in adults, we examined 201 patients who had a cough for 2-12 weeks and no pulmonary disease. We obtained the following at presentation: medical history, chest radiograph, respiratory function measurement, nasopharyngeal aspirate for polymerase chain reaction (PCR), nasopharyngeal swab specimen for culture, and a blood sample (acute serum). Four weeks later a second blood sample (convalescent serum) was obtained. Control sera were obtained from 164 age-matched healthy blood donors with no history of cough during the previous 12 weeks. Four patients were B. pertussis culture-positive; 11 (including the culture-positive patients) were B. pertussis PCR-positive; and 33, including 10 of the 11 PCR-positive patients, had serological evidence of recent B. pertussis infection. Pertussis-positive and -negative patients could not be discriminated by a history of cough. We conclude that B. pertussis infection is a common cause of persistent cough in adults. This is of concern, because these patients may be B. pertussis reservoirs from which transmission may occur to infants, in whom the disease can be devastating.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524969     DOI: 10.1086/313448

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

Authors:  Tine Dalby; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Pertussis in adults with persistent cough in South Korea.

Authors:  W B Park; S W Park; H B Kim; E C Kim; M Oh; K W Choe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

3.  Pathogen adaptation under imperfect vaccination: implications for pertussis.

Authors:  Michiel van Boven; Frits R Mooi; Joop F P Schellekens; Hester E de Melker; Mirjam Kretzschmar
Journal:  Proc Biol Sci       Date:  2005-08-07       Impact factor: 5.349

4.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 5.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

6.  Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.

Authors:  Casandra Hoffman; Joshua Eby; Mary Gray; F Heath Damron; Jeffrey Melvin; Peggy Cotter; Erik Hewlett
Journal:  Mol Microbiol       Date:  2016-11-03       Impact factor: 3.501

7.  Feed-forward and reciprocal inhibition for gain and phase timing control in a computational model of repetitive cough.

Authors:  Teresa Pitts; Kendall F Morris; Lauren S Segers; Ivan Poliacek; Melanie J Rose; Bruce G Lindsey; Paul W Davenport; Dena R Howland; Donald C Bolser
Journal:  J Appl Physiol (1985)       Date:  2016-06-09

8.  Nasopharyngeal pertussis toxin IgA antibodies in the diagnosis of pertussis in Australian community patients.

Authors:  D Norman; M Karimi; A Herbert; M H Beaman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-13       Impact factor: 3.267

Review 9.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 10.  Cough. 1: Chronic cough in adults.

Authors:  A H Morice; J A Kastelik
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.